MARKET

BNGO

BNGO

Bionano Genomics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.41
+0.10
+1.88%
After Hours: 5.45 +0.04 +0.74% 19:59 05/07 EDT
OPEN
5.42
PREV CLOSE
5.31
HIGH
5.73
LOW
5.32
VOLUME
16.20M
TURNOVER
--
52 WEEK HIGH
15.69
52 WEEK LOW
0.3350
MARKET CAP
1.51B
P/E (TTM)
-10.0167
1D
5D
1M
3M
1Y
5Y
Bionano Genomics to Report First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 13, 2021
SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, May 13, 2021 at 4:30 p.m. Eastern Time to report financial results for the first quarter end...
GlobeNewswire · 2d ago
Bionano Genomics secures new patent in U.S.
The USPTO will issue Bionano Genomics ([[BNGO]] -4.4%) U.S. Patent No. 10,995,364 today. The patent, titled “METHODS AND DEVICES FOR SINGLE-MOLECULE WHOLE GENOME ANALYSIS” covers methods for labeling DNA molecules with
Seekingalpha · 4d ago
Bionano Genomics Announces Issuance of US Patent for Targeted Labeling Strategy to Complement Whole Genome Analysis Using Optical Genome Mapping
GlobeNewswire · 5d ago
BRIEF-Bionano Genomics Says Georgia Esoteric And Molecular Laboratory Now Offers Diagnostic Service For Genetic Disorders
reuters.com · 6d ago
Georgia Esoteric and Molecular Laboratory at Augusta University Now Offers Diagnostic Service for Constitutional Genetic Disorders based on Optical Genome Mapping with Bionano’s Saphyr System
SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that the Georgia Esoteric and Molecular (GEM) Laboratory at the Medical College of Georgia (MCG) at Augusta University is now offering diagnostic services fo...
GlobeNewswire · 6d ago
Bionano Genomics, Inc. (BNGO) Dips More Than Broader Markets: What You Should Know
Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.97, moving -1.13% from the previous trading session.
Zacks · 04/28 21:50
Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc.
Benzinga · 04/27 16:03
58 Biggest Movers From Yesterday
Gainers
Benzinga · 04/27 09:03
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BNGO. Analyze the recent business situations of Bionano Genomics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BNGO stock price target is 13.92 with a high estimate of 15.00 and a low estimate of 12.75.
EPS
Institutional Holdings
Institutions: 55
Institutional Holdings: 11.67M
% Owned: 4.19%
Shares Outstanding: 278.79M
TypeInstitutionsShares
Increased
8
2.05M
New
28
3.09M
Decreased
7
1.03M
Sold Out
7
1.09M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.95%
Healthcare Equipment & Supplies
+0.66%
Key Executives
Chairman/Independent Director
David Barker
President/Chief Executive Officer/Director
R. Erik Holmlin
President/Chief Executive Officer/Director
R Holmlin
Chief Operating Officer
Mark Borodkin
Chief Financial Officer
Christopher Stewart
Chief Operating Officer
Mark Oldakowski
Other
Alka Chaubey
Director
Yvonne Linney
Director
Hannah Mamuszka
Independent Director
Albert Luderer
Independent Director
Christopher Twomey
Independent Director
Kristiina Vuori
No Data
About BNGO
Bionano Genomics, Inc. is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response. The Company’s subsidiary, Lineagen, Inc., provides molecular diagnostics services for individuals.

Webull offers kinds of BioNano Genomics Inc stock information, including NASDAQ:BNGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNGO stock methods without spending real money on the virtual paper trading platform.